stoxline Quote Chart Rank Option Currency Glossary
  
Zimmer Biomet Holdings, Inc. (ZBH)
98.98  -1.44 (-1.43%)    02-11 16:00
Open: 99.63
High: 100.39
Volume: 1,497,281
  
Pre. Close: 100.42
Low: 98.97
Market Cap: 19,704(M)
Technical analysis
2025-02-11 4:50:45 PM
Short term     
Mid term     
Targets 6-month :  126.33 1-year :  132.96
Resists First :  108.15 Second :  113.83
Pivot price 107.62
Supports First :  98.97 Second :  82.34
MAs MA(5) :  102.25 MA(20) :  107.73
MA(100) :  107.13 MA(250) :  112.83
MACD MACD :  -1.6 Signal :  -0.3
%K %D K(14,3) :  4.1 D(3) :  9.1
RSI RSI(14): 27
52-week High :  133.89 Low :  98.97
Price, MAs and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.
[ ZBH ] has closed above bottom band by 0.8%. Bollinger Bands are 131.1% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 2 days. This is a sign that the current trend might continue.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 100.54 - 101.24 101.24 - 101.78
Low: 97.11 - 98.08 98.08 - 98.81
Close: 97.66 - 98.95 98.95 - 99.94
Company Description

Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates in the musculoskeletal healthcare business in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company designs, manufactures, and markets orthopaedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, biologics, foot and ankle, extremities, and trauma products; spine products comprising medical devices and surgical instruments; and face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest toss facilitate healing or reconstruction after open heart surgery, trauma, or for deformities of the chest. It also offers dental products that include dental reconstructive implants, and dental prosthetic and regenerative products, as well as robotic, surgical and bone cement products. The company's products and solutions are used to treat patients suffering from disorders of, or injuries to, bones, joints, or supporting soft tissues. It serves orthopedic surgeons, neurosurgeons, oral surgeons, dentists, hospitals, stocking distributors, healthcare dealers, and other specialists, as well as agents, healthcare purchasing organizations, or buying groups. The company was formerly known as Zimmer Holdings, Inc. and changed its name to Zimmer Biomet Holdings, Inc. in June 2015. Zimmer Biomet Holdings, Inc. was founded in 1927 and is headquartered in Warsaw, Indiana.

Headline News

Mon, 10 Feb 2025
Zimmer Biomet Holdings Stock: A Deep Dive Into Analyst Perspectives (9 Ratings) - Benzinga

Sun, 09 Feb 2025
Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Q4 2024 Earnings Call Transcript - MSN

Fri, 07 Feb 2025
Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Q4 2024 Earnings Call Transcript - Insider Monkey

Fri, 07 Feb 2025
Zimmer Biomet - Adding To The Growth Profile (NYSE:ZBH) - Seeking Alpha

Fri, 07 Feb 2025
Zimmer Biomet Holdings Inc (ZBH) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and ... - Yahoo Finance

Thu, 06 Feb 2025
Why Is Zimmer Biomet Stock Trading Lower On Thursday? - Benzinga

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Neutral
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Underperform
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Outperform
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Underperform
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Underperform
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Underperform
Stock Basics & Statistics
Exchange:
NYSE
Sector:
Healthcare
Industry:
Medical - Devices
Shares Out 199 (M)
Shares Float 199 (M)
Held by Insiders 0.1 (%)
Held by Institutions 93.1 (%)
Shares Short 7,630 (K)
Shares Short P.Month 6,770 (K)
Stock Financials
EPS 5.23
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 62
Profit Margin 14.2 %
Operating Margin 18 %
Return on Assets (ttm) 4.6 %
Return on Equity (ttm) 8.7 %
Qtrly Rev. Growth 4 %
Gross Profit (p.s.) 27.42
Sales Per Share 38.17
EBITDA (p.s.) 12.85
Qtrly Earnings Growth 59.7 %
Operating Cash Flow 1,580 (M)
Levered Free Cash Flow 1,220 (M)
Stock Valuations
PE Ratio 18.88
PEG Ratio 0
Price to Book value 1.59
Price to Sales 2.59
Price to Cash Flow 12.47
Stock Dividends
Dividend 0.23
Forward Dividend 0
Dividend Yield 0.2%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android